173 related articles for article (PubMed ID: 22870533)
1. Hypofractionated radiation therapy for prostate cancer: risks and potential benefits in a fiscally conservative health care system.
Aneja S; Pratiwadi RR; Yu JB
Oncology (Williston Park); 2012 Jun; 26(6):512-8. PubMed ID: 22870533
[TBL] [Abstract][Full Text] [Related]
2. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
3. The changing costs of radiation treatment for early prostate cancer in Ontario: a comparison between conventional and conformal external beam radiotherapy.
Poon I; Pintilie M; Potvin M; McGowan T
Can J Urol; 2004 Feb; 11(1):2125-32. PubMed ID: 15003151
[TBL] [Abstract][Full Text] [Related]
4. Lack of benefit from a short course of androgen deprivation for unfavorable prostate cancer patients treated with an accelerated hypofractionated regime.
Martinez AA; Demanes DJ; Galalae R; Vargas C; Bertermann H; Rodriguez R; Gustafson G; Altieri G; Gonzalez J
Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1322-31. PubMed ID: 16029788
[TBL] [Abstract][Full Text] [Related]
5. Hypofractionated Radiotherapy for Localized Prostate Cancer: A Challenging Accelerated Hypofractionated Radiotherapy.
Yamazaki H; Nakamura S; Suzuki G; Yoshida K; Yoshioka Y; Koizumi M; Ogawa K
Anticancer Res; 2015 Oct; 35(10):5167-77. PubMed ID: 26408674
[TBL] [Abstract][Full Text] [Related]
6. External beam irradiation for localized prostate cancer--the promise of hypofractionation.
Loblaw DA; Cheung P
Can J Urol; 2006 Feb; 13 Suppl 1():62-6. PubMed ID: 16526985
[TBL] [Abstract][Full Text] [Related]
7. Patient costs associated with external beam radiotherapy treatment for localized prostate cancer: the benefits of hypofractionated over conventionally fractionated radiotherapy.
Sethukavalan P; Cheung P; Tang CI; Quon H; Morton G; Nam R; Loblaw A
Can J Urol; 2012 Apr; 19(2):6165-9. PubMed ID: 22512958
[TBL] [Abstract][Full Text] [Related]
8. Hypofractionated radiation therapy (66 Gy in 22 fractions at 3 Gy per fraction) for favorable-risk prostate cancer: long-term outcomes.
Patel N; Faria S; Cury F; David M; Duclos M; Shenouda G; Ruo R; Souhami L
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):534-9. PubMed ID: 23597418
[TBL] [Abstract][Full Text] [Related]
9. Hypofractionated radiotherapy in prostate cancer.
Vavassis P; Nguyen DH; Bahary JP; Yassa M
Expert Rev Anticancer Ther; 2012 Jul; 12(7):965-72. PubMed ID: 22845411
[TBL] [Abstract][Full Text] [Related]
10. Radiobiological rationale and clinical implications of hypofractionated radiation therapy.
Ko EC; Forsythe K; Buckstein M; Kao J; Rosenstein BS
Cancer Radiother; 2011 Jun; 15(3):221-9. PubMed ID: 21514198
[TBL] [Abstract][Full Text] [Related]
11. Whole-pelvic nodal radiation therapy in the context of hypofractionation for high-risk prostate cancer patients: a step forward.
Kaidar-Person O; Roach M; Créhange G
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):600-5. PubMed ID: 23523182
[TBL] [Abstract][Full Text] [Related]
12. Image guided hypofractionated radiotherapy and quality of life for localized prostate cancer: prospective longitudinal study in 337 patients.
Jereczek-Fossa BA; Santoro L; Zerini D; Fodor C; Vischioni B; Dispinzieri M; Bossi-Zanetti I; Gherardi F; Bonora M; Caputo M; Vavassori A; Cambria R; Garibaldi C; Cattani F; Matei DV; Musi G; De Cobelli O; Orecchia R
J Urol; 2013 Jun; 189(6):2099-103. PubMed ID: 23313200
[TBL] [Abstract][Full Text] [Related]
13. Accelerated hypofractionated adjuvant whole breast radiotherapy with concomitant photon boost after conserving surgery for early stage breast cancer: a prospective evaluation on 463 patients.
Cante D; Rosa La Porta M; Casanova-Borca V; Sciacero P; Girelli G; Pasquino M; Franco P; Ozzello F
Breast J; 2011; 17(6):586-93. PubMed ID: 21951485
[TBL] [Abstract][Full Text] [Related]
14. Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Katoh H; Noda SE; Ito K; Yamamoto T; Kashiwagi B; Nakano T
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):472-8. PubMed ID: 16168839
[TBL] [Abstract][Full Text] [Related]
15. High-dose external beam radiation for localized prostate cancer: current status and future challenges.
Nguyen PL; Zietman AL
Cancer J; 2007; 13(5):295-301. PubMed ID: 17921728
[TBL] [Abstract][Full Text] [Related]
16. Systematic review of hypofractionated radiation therapy for prostate cancer.
Zaorsky NG; Ohri N; Showalter TN; Dicker AP; Den RB
Cancer Treat Rev; 2013 Nov; 39(7):728-36. PubMed ID: 23453861
[TBL] [Abstract][Full Text] [Related]
17. Single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for men with intermediate-risk prostate cancer: analysis of short- and medium-term toxicity and quality of life.
Morton GC; Loblaw DA; Sankreacha R; Deabreu A; Zhang L; Mamedov A; Cheung P; Keller B; Danjoux C; Szumacher E; Thomas G
Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):811-7. PubMed ID: 19836166
[TBL] [Abstract][Full Text] [Related]
18. ACR Appropriateness Criteria® definitive external beam irradiation in stage T1 and T2 prostate cancer.
Moran BJ; DeRose P; Hsu IC; Abdel-Wahab M; Arterbery VE; Ciezki JP; Frank SJ; Mohler JL; Rosenthal SA; Rossi CJ; Yamada Y; Merrick GS
Am J Clin Oncol; 2011 Dec; 34(6):636-47. PubMed ID: 22101389
[TBL] [Abstract][Full Text] [Related]
19. Hypofractionated radiotherapy for prostate cancer.
Hegemann NS; Guckenberger M; Belka C; Ganswindt U; Manapov F; Li M
Radiat Oncol; 2014 Dec; 9():275. PubMed ID: 25480014
[TBL] [Abstract][Full Text] [Related]
20. Certificate of need programs, intensity modulated radiation therapy use and the cost of prostate cancer care.
Khanna A; Hu JC; Gu X; Nguyen PL; Lipsitz S; Palapattu GS
J Urol; 2013 Jan; 189(1):75-9. PubMed ID: 23164382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]